ES2140821T3 - Deteccion de la produccion de anticuerpos. - Google Patents

Deteccion de la produccion de anticuerpos.

Info

Publication number
ES2140821T3
ES2140821T3 ES96903122T ES96903122T ES2140821T3 ES 2140821 T3 ES2140821 T3 ES 2140821T3 ES 96903122 T ES96903122 T ES 96903122T ES 96903122 T ES96903122 T ES 96903122T ES 2140821 T3 ES2140821 T3 ES 2140821T3
Authority
ES
Spain
Prior art keywords
antibody
detection
antigen
absence
union
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96903122T
Other languages
English (en)
Inventor
Lars Reinhardt Haaheim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2140821T3 publication Critical patent/ES2140821T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56994Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UN METODO PARA DETECTAR LA PRODUCCION ACTIVA DE ANTICUERPOS EN UNA MUESTRA DE SANGRE, COMPRENDIENDO DICHO METODO EL CONTACTO, EN PRESENCIA O AUSENCIA DE UN INHIBIDOR DE LA SINTESIS PROTEICA, DE ALICUOTAS DE DICHA MUESTRA CON UNA FASE SOLIDA EN CONDICIONES QUE PERMITEN LA PRODUCCION Y SECRECION DE ANTICUERPO POR LOS LINFOCITOS; LA DETECCION EN SOLUCION LA UNION DEL ANTICUERPO CON DICHO(S) ANTIGENO(S) EN LA FASE SOLIDA; Y LA COMPARACION DICHA UNION DE ANTICUERPO EN PRESENCIA O AUSENCIA DE INHIBIDOR DE LA SINTESIS PROTEICA, OBTENIENDOSE ASI UNA DETERMINACION DE LA CANTIDAD DE SECRECION ACTIVA DE ANTICUERPO EN RESPUESTA A DICHO(S) ANTIGENO(S); Y KITS PARA PONER EN PRACTICA EL METODO. EL METODO PUEDE MODIFICARSE PARA PERMITIR LA DETECCION DE INDICADORES NO ESPECIFICOS DE LA INFECCION.
ES96903122T 1995-02-21 1996-02-21 Deteccion de la produccion de anticuerpos. Expired - Lifetime ES2140821T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9503406.2A GB9503406D0 (en) 1995-02-21 1995-02-21 Detection of antibody production

Publications (1)

Publication Number Publication Date
ES2140821T3 true ES2140821T3 (es) 2000-03-01

Family

ID=10769981

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96903122T Expired - Lifetime ES2140821T3 (es) 1995-02-21 1996-02-21 Deteccion de la produccion de anticuerpos.

Country Status (21)

Country Link
US (1) US6080552A (es)
EP (1) EP0811165B1 (es)
JP (1) JP3472929B2 (es)
CN (1) CN1098460C (es)
AT (1) ATE188551T1 (es)
AU (1) AU709591B2 (es)
CA (1) CA2213083C (es)
CZ (1) CZ289582B6 (es)
DE (1) DE69606024T2 (es)
DK (1) DK0811165T3 (es)
ES (1) ES2140821T3 (es)
FI (1) FI117911B (es)
GB (1) GB9503406D0 (es)
GR (1) GR3032740T3 (es)
HU (1) HU225687B1 (es)
NO (1) NO317151B1 (es)
NZ (1) NZ301770A (es)
PL (1) PL182061B1 (es)
PT (1) PT811165E (es)
RU (1) RU2197733C2 (es)
WO (1) WO1996026443A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955544A1 (de) * 1998-05-06 1999-11-10 Hölzel Diagnostika Handels GmbH Verfahren zum Erfassen von Primärsignalen bei der Zellkommunikation von Zellen des Immunsystems
GB9913819D0 (en) * 1999-06-14 1999-08-11 Plasmacute As Assay
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
US20050240353A1 (en) * 2004-04-21 2005-10-27 Hoffmann Technologies Corporation Reagents, devices and methods for proteomic analysis with applications including diagnostics, vaccines, quality control and research
JP4412732B2 (ja) * 2005-04-19 2010-02-10 独立行政法人国立高等専門学校機構 リンパ球を利用した抗体検査方法および病原体特定方法
DE102007052518A1 (de) * 2007-10-29 2009-04-30 Autoimmun Diagnostika Gmbh Verfahren zur in vitro-Diagnose und/oder in vitro- Therapieverfolgung von Infektionen
WO2015170199A1 (en) 2014-05-05 2015-11-12 Cembre S.P.A. Machine for the application and / or removal of connecting fasteners for rails
RU2756764C1 (ru) * 2021-06-09 2021-10-05 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр терапии и профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ТПМ" Минздрава России) Способ определения функциональной активности системы комплемента человека для прогноза тяжести течения системной воспалительной реакции

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019497A (en) * 1984-11-09 1991-05-28 Lennart Olsson Human squamous lung carcinoma cell specific antigens and antibodies
US4707443A (en) * 1985-04-19 1987-11-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same
CA2011099A1 (en) * 1989-04-19 1990-10-19 Stephen C. Wardlaw Determination of lymphocyte reactivity to specific antigens in blood
US5188942A (en) * 1990-10-09 1993-02-23 Consultants For Applied Biosciences, Inc. Method for determining bluetongue virus antibodies in serum

Also Published As

Publication number Publication date
NZ301770A (en) 1999-04-29
PL182061B1 (pl) 2001-10-31
ATE188551T1 (de) 2000-01-15
DK0811165T3 (da) 2000-05-08
EP0811165B1 (en) 2000-01-05
CN1098460C (zh) 2003-01-08
GR3032740T3 (en) 2000-06-30
AU709591B2 (en) 1999-09-02
NO973823D0 (no) 1997-08-20
WO1996026443A1 (en) 1996-08-29
US6080552A (en) 2000-06-27
CN1176000A (zh) 1998-03-11
EP0811165A1 (en) 1997-12-10
PT811165E (pt) 2000-04-28
CA2213083C (en) 2007-12-04
DE69606024D1 (de) 2000-02-10
HUP9801448A3 (en) 2000-09-28
HUP9801448A2 (hu) 1998-10-28
GB9503406D0 (en) 1995-04-12
NO973823L (no) 1997-10-20
PL322209A1 (en) 1998-01-19
AU4726896A (en) 1996-09-11
NO317151B1 (no) 2004-08-30
FI973418A (fi) 1997-08-20
CZ263497A3 (cs) 1998-02-18
DE69606024T2 (de) 2000-09-14
HU225687B1 (en) 2007-06-28
FI973418A0 (fi) 1997-08-20
JPH11500226A (ja) 1999-01-06
FI117911B (fi) 2007-04-13
JP3472929B2 (ja) 2003-12-02
CZ289582B6 (cs) 2002-02-13
CA2213083A1 (en) 1996-08-29
RU2197733C2 (ru) 2003-01-27

Similar Documents

Publication Publication Date Title
CA1268419A (en) Immunoassay for htlv-iii antigens
US4609629A (en) Process for the immunological determination of proteins in body fluid which display a non-parallel inhibition curve to a reference inhibitor
JPH01150856A (ja) 抗原および抗体の同時免疫定量法
ATE318147T1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
ES2187947T3 (es) Procedimiento para la determinacion simultanea de antigenos de hiv y anticuerpos de hiv.
ES2140821T3 (es) Deteccion de la produccion de anticuerpos.
DK0755517T3 (da) Fremgangsmåde til detektion af tilstedeværelse af en Mycobacterium-art og et kit og antistoffer til anvendelse i denne
CA2361000A1 (en) Urinary trypsin inhibitor to diagnose aids
US4816387A (en) Method for detection of antibodies to HTLV-III and diagnostic test kit useful therewith
ES2122292T3 (es) Diagnosis precoz de sepsis utilizando interacciones antigeno-anticuerpo amplificadas por quimioluminiscencia de sangre completa.
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
JPH04177166A (ja) ヒトc―ペプチドの測定方法
ATE391914T1 (de) Assay
Krupin et al. Long-range surface plasmon waveguide biosensors for disease detection
RU94020434A (ru) Способ и набор для обнаружения вируса лихорадки долины рифт и антител к нему в биологических материалах
ATE208041T1 (de) A-protein als diagnostikum für krebs
ES2075803A1 (es) Procedimiento de la deteccion de neumolisina
Finn Development of an enzyme immunoassay for the measurement of serum antibody of C. trachomatis
DE3853282T2 (de) Diagnostischer Test für Pseudomonas Aeruginosa Infektionen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 811165

Country of ref document: ES